Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Mol Diagn ; 23(10): 1306-1323, 2021 10.
Article in English | MEDLINE | ID: mdl-34358678

ABSTRACT

Breast cancer is one of the leading causes of mortality in women worldwide, and neoadjuvant chemotherapy has emerged as an option for the management of locally advanced breast cancer. Extensive efforts have been made to identify new molecular markers to predict the response to neoadjuvant chemotherapy. Transcripts that do not encode proteins, termed long noncoding RNAs (lncRNAs), have been shown to display abnormal expression profiles in different types of cancer, but their role as biomarkers in response to neoadjuvant chemotherapy has not been extensively studied. Herein, lncRNA expression was profiled using RNA sequencing in biopsies from patients who subsequently showed either response or no response to treatment. GATA3-AS1 was overexpressed in the nonresponder group and was the most stable feature when performing selection in multiple random forest models. GATA3-AS1 was experimentally validated by quantitative RT-PCR in an extended group of 68 patients. Expression analysis confirmed that GATA3-AS1 is overexpressed primarily in patients who were nonresponsive to neoadjuvant chemotherapy, with a sensitivity of 92.9% and a specificity of 75.0%. The statistical model was based on luminal B-like patients and adjusted by menopausal status and phenotype (odds ratio, 37.49; 95% CI, 6.74-208.42; P = 0.001); GATA3-AS1 was established as an independent predictor of response. Thus, lncRNA GATA3-AS1 is proposed as a potential predictive biomarker of nonresponse to neoadjuvant chemotherapy.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/genetics , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Drug Resistance, Neoplasm/genetics , GATA3 Transcription Factor/genetics , Neoadjuvant Therapy/methods , RNA, Antisense/genetics , RNA, Long Noncoding/genetics , Transcriptome/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adult , Biomarkers, Tumor/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cohort Studies , Female , Gene Expression Regulation, Neoplastic , Humans , MCF-7 Cells , Middle Aged , Prognosis , RNA-Seq/methods , Receptor, ErbB-2/metabolism , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...